Gene · 3914
Papers1,750
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,750
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Status of Human Papillomavirus Infection and Cervical Cancer in the Philippines. | Front Med (Lausanne) | 2022 | 35795639 | PubTator, text mining | PubMed |
| PARD3 gene variation as candidate cause of nonsyndromic cleft palate only. | J Cell Mol Med | 2022 | 35789100 | PubTator, text mining | PubMed |
| ABCA12 Promotes Proliferation and Migration and Inhibits Apoptosis of Pancreatic Cancer Cells Through the AKT Signaling Pathway. | Front Genet | 2022 | 35783291 | PubTator, text mining | PubMed |
| Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer. | Ther Adv Med Oncol | 2022 | 35782750 | PubTator, text mining | PubMed |
| Development and clinical translation of ex vivo gene therapy. | Comput Struct Biotechnol J | 2022 | 35782737 | PubTator, text mining | PubMed |
| Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications. | Ann Surg Oncol | 2022 | 35780216 | PubTator, text mining | PubMed |
| The dynamic roles of the bladder tumour microenvironment. | Nat Rev Urol | 2022 | 35764795 | PubTator, text mining | PubMed |
| A dual-activity topoisomerase complex regulates mRNA translation and turnover. | Nucleic Acids Res | 2022 | 35748872 | PubTator, text mining | PubMed |
| Tracking the Molecular Scenarios for Tumorigenic Remodeling of Extracellular Matrix Based on Gene Expression Profiling in Equine Skin Neoplasia Models. | Int J Mol Sci | 2022 | 35742950 | PubTator, text mining | PubMed |
| Comprehensive Integrated Single-Cell Whole Transcriptome Analysis Revealed the p-EMT Tumor Cells-CAFs Communication in Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2022 | 35742914 | PubTator, text mining | PubMed |
| Epidermolysis Bullosa-A Different Genetic Approach in Correlation with Genetic Heterogeneity. | Diagnostics (Basel) | 2022 | 35741135 | PubTator, text mining | PubMed |
| Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects. | Biomedicines | 2022 | 35740242 | PubTator, text mining | PubMed |
| First case report of complete paternal isodisomy of chromosome 10 harbouring a novel variant in COL17A1 that causes junctional epidermolysis bullosa intermediate. | BMC Med Genomics | 2022 | 35717189 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Uncover Key Regulators of Skin Regeneration in Human Long-Term Mechanical Stretch-Mediated Expansion Therapy. | Front Cell Dev Biol | 2022 | 35712657 | PubTator, text mining | PubMed |
| Isolated steroid-resistant nephrotic syndrome in a Chinese child carrying a de novo mutation in WT1 gene:a case report and literature review. | BMC Pediatr | 2022 | 35710404 | PubTator, text mining | PubMed |
| Identification and characterization of stem cells in mammalian esophageal stratified squamous epithelia. | J Mol Cell Biol | 2022 | 35709398 | PubTator, text mining | PubMed |
| Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host. | Virus Evol | 2022 | 35706980 | PubTator, text mining | PubMed |
| 100 plus years of stem cell research-20 years of ISSCR. | Stem Cell Reports | 2022 | 35705014 | PubTator, text mining | PubMed |
| From COVID to fibrosis: lessons from single-cell analyses of the human lung. | Hum Genomics | 2022 | 35698166 | PubTator, text mining | PubMed |
| The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes. | Skin Pharmacol Physiol | 2022 | 35696989 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3914/papers?page=20